Edition:
United Kingdom

Celcuity Inc (CELC.OQ)

CELC.OQ on NASDAQ Stock Exchange Capital Market

17.40USD
21 Feb 2018
Change (% chg)

$-0.22 (-1.25%)
Prev Close
$17.62
Open
$17.75
Day's High
$17.75
Day's Low
$17.20
Volume
14,463
Avg. Vol
9,977
52-wk High
$22.13
52-wk Low
$11.10

Chart for

About

Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)

Overall

Beta: --
Market Cap(Mil.): $126.97
Shares Outstanding(Mil.): 9.72
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 83.93 16.60
EPS (TTM): -- -- --
ROI: -- 1.66 10.66
ROE: -- 2.58 14.30

BRIEF-Celcuity reports Q3 loss $0.26/shr

* Celcuity reports third quarter fiscal 2017 financial results

13 Nov 2017

BRIEF-Celcuity announces pricing of initial public offering

* Celcuity Llc - ‍announced today pricing of its upsized IPO of 2,400,000 shares of its common stock at a public offering price of $9.50 per share​

20 Sep 2017

Earnings vs. Estimates